GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice

被引：25

作者：

Quarta, Carmelo ^{[1
,2
,3
]}

Stemmer, Kerstin ^{[1
,2
,4
]}

Novikoff, Aaron ^{[1
,2
,5
]}

Yang, Bin ^{[6
]}

Klingelhuber, Felix ^{[1
,2
]}

Harger, Alex ^{[1
,2
]}

Bakhti, Mostafa ^{[2
,7
]}

Bastidas-Ponce, Aimee ^{[2
,7
]}

Bauge, Eric ^{[8
]}

Campbell, Jonathan E. ^{[9
]}

Capozzi, Megan ^{[9
]}

Clemmensen, Christoffer ^{[10
]}

Collden, Gustav ^{[12
]}

Cota, Perla ^{[2
,7
]}

Douros, Jon ^{[6
]}

Drucker, Daniel J. ^{[11
]}

DuBois, Barent ^{[6
]}

Feuchtinger, Annette ^{[12
]}

Garcia-Caceres, Cristina ^{[1
,2
]}

Grandl, Gerald ^{[1
,2
]}

Hennuyer, Nathalie ^{[8
]}

Herzig, Stephan ^{[2
,13
]}

Hofmann, Susanna M. ^{[2
,7
,14
]}

Knerr, Patrick J. ^{[6
]}

Kulaj, Konxhe ^{[1
,2
]}

Lalloyer, Fanny ^{[8
]}

Lickert, Heiko ^{[2
,7
]}

Liskiewicz, Arek ^{[1
,2
]}

Liskiewicz, Daniela ^{[1
,2
]}

Maity, Gandhari ^{[1
,2
]}

Perez-Tilve, Diego ^{[15
]}

Prakash, Sneha ^{[1
,2
]}

Sanchez-Garrido, Miguel A. ^{[16
]}

Zhang, Qian ^{[1
,2
]}

Staels, Bart ^{[8
]}

Krahmer, Natalie ^{[1
,2
]}

DiMarchi, Richard D. ^{[17
]}

Tschoep, Matthias H. ^{[2
,5
,18
]}

Finan, Brian ^{[6
]}

Mueller, Timo D. ^{[1
,2
]}

机构：

[1] Helmholtz Zentrum Munchen, Inst Diabet & Obes, Neuherberg, Germany

[2] German Ctr Diabet Res DZD, Neuherberg, Germany

[3] Univ Bordeaux, Neuroctr Magendie, INSERM, Bordeaux, France

[4] Univ Augsburg, Inst Theoret Med, Mol Cell Biol, Augsburg, Germany

[5] Tech Univ Munich, Dept Med, Div Metab Dis, Munich, Germany

[6] Novo Nordisk Res Ctr Indianapolis, Indianapolis, IN 46204 USA

[7] Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Neuherberg, Germany

[8] Univ Lille, Inst Pasteur Lille, European Genom Inst Genom, INSERM,CHU Lille, Lille, France

[9] Duke Univ, Dept Med, Div Endocrinol, Durham, NC USA

[10] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark

[11] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

[12] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, German Res Ctr Environm Hlth, Neuherberg, Germany

[13] Helmholtz Ctr Munich, Helmholtz Diabet Ctr, Inst Diabet & Canc, Neuherberg, Germany

[14] Ludwig Maximilians Univ Munchen, Med Clin & Polyclin 4, Munich, Germany

[15] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH USA

[16] Univ Cordoba, Fac Med, Dept Cell Biol Physiol & Immunol, Cordoba, Spain

[17] Indiana Univ, Dept Chem, Bloomington, IN USA

[18] Helmholtz Zentrum Munchen, Neuherberg, Germany

来源：

NATURE METABOLISM | 2022年 / 4卷 / 08期

基金：

欧洲研究理事会;

关键词：

PPAR-GAMMA; PEPTIDE-1; RECEPTOR; EXPRESSION; GLUCAGON; PREVENTION; REVERSES; SAFETY; TRIAL;

D O I：

10.1038/s42255-022-00617-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A conjugate drug consisting of GLP-1 receptor agonist and the PPARalpha/gamma dual-agonist tesaglitazar is shown to have superior anti-diabetic effects than monotherapy. Dual agonists activating the peroxisome proliferator-activated receptors alpha and gamma (PPARalpha/gamma) have beneficial effects on glucose and lipid metabolism in patients with type 2 diabetes, but their development was discontinued due to potential adverse effects. Here we report the design and preclinical evaluation of a molecule that covalently links the PPARalpha/gamma dual-agonist tesaglitazar to a GLP-1 receptor agonist (GLP-1RA) to allow for GLP-1R-dependent cellular delivery of tesaglitazar. GLP-1RA/tesaglitazar does not differ from the pharmacokinetically matched GLP-1RA in GLP-1R signalling, but shows GLP-1R-dependent PPAR gamma-retinoic acid receptor heterodimerization and enhanced improvements of body weight, food intake and glucose metabolism relative to the GLP-1RA or tesaglitazar alone in obese male mice. The conjugate fails to affect body weight and glucose metabolism in GLP-1R knockout mice and shows preserved effects in obese mice at subthreshold doses for the GLP-1RA and tesaglitazar. Liquid chromatography-mass spectrometry-based proteomics identified PPAR regulated proteins in the hypothalamus that are acutely upregulated by GLP-1RA/tesaglitazar. Our data show that GLP-1RA/tesaglitazar improves glucose control with superior efficacy to the GLP-1RA or tesaglitazar alone and suggest that this conjugate might hold therapeutic value to acutely treat hyperglycaemia and insulin resistance.

引用

页码：1071 / +

页数：23

共 42 条

[21] Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (α/γ) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy [J].

Kendall, DM ;

Rubin, CJ ;

Mohideen, P ;

Ledeine, JM ;

Belder, R ;

Gross, J ;

Norwood, P ;

O'Mahony, M ;

Sall, K ;

Sloan, G ;

Roberts, A ;

Fiedorek, FT ;

DeFronzo, RA .

DIABETES CARE, 2006, 29 (05) :1016-1023

[22] Internalization Dissociates β2-Adrenergic Receptors [J].

Lan, Tien-Hung ;

Kuravi, Sudhakiranmayi ;

Lambert, Nevin A. .

PLOS ONE, 2011, 6 (02)

[23] Thiazolidinediones: the Forgotten Diabetes Medications [J].

Lebovitz, Harold E. .

CURRENT DIABETES REPORTS, 2019, 19 (12)

[24] Hypothalamic peroxisome proliferator-activated receptor gamma regulates ghrelin production and food intake [J].

Li, Qingjie ;

Yu, Quan ;

Lin, Li ;

Zhang, Heng ;

Peng, Miao ;

Jing, Chunxia ;

Xu, Geyang .

NEUROPEPTIDES, 2018, 69 :39-45

[25] Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones [J].

Lu, Min ;

Sarruf, David A. ;

Talukdar, Saswata ;

Sharma, Shweta ;

Li, Pingping ;

Bandyopadhyay, Gautam ;

Nalbandian, Sarah ;

Fan, WuQiang ;

Gayen, Jiaur R. ;

Mahata, Sushil K. ;

Webster, Nicholas J. ;

Schwartz, Michael W. ;

Olefsky, Jerrold M. .

NATURE MEDICINE, 2011, 17 (05) :618-U140

[26] ESTABLISHMENT OF A PANCREATIC BETA-CELL LINE THAT RETAINS GLUCOSE-INDUCIBLE INSULIN-SECRETION - SPECIAL REFERENCE TO EXPRESSION OF GLUCOSE TRANSPORTER ISOFORMS [J].

MIYAZAKI, JI ;

ARAKI, K ;

YAMATO, E ;

IKEGAMI, H ;

ASANO, T ;

SHIBASAKI, Y ;

OKA, Y ;

YAMAMURA, KI .

ENDOCRINOLOGY, 1990, 127 (01) :126-132

[27] PPAR control of metabolism and cardiovascular functions [J].

Montaigne, David ;

Butruille, Laura ;

Staels, Bart .

NATURE REVIEWS CARDIOLOGY, 2021, 18 (12) :809-823

[28] Analysis of RXR/THR and RXR/PPARG2 Heterodimerization by Bioluminescence Resonance Energy Transfer (BRET) [J].

Mulero, Miquel ;

Perroy, Julie ;

Federici, Carole ;

Cabello, Gerard ;

Ollendorff, Vincent .

PLOS ONE, 2013, 8 (12)

[29] Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides [J].

Nikan, Mehran ;

Tanowitz, Michael ;

Dwyer, Chrissa A. ;

Jackson, Michaela ;

Gaus, Hans J. ;

Swayze, Eric E. ;

Rigo, Frank ;

Seth, Punit P. ;

Prakash, Thazha P. .

JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (15) :8471-8484

[30] Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles [J].

Porrello, Enzo R. ;

Pfleger, Kevin D. G. ;

Seeber, Ruth M. ;

Qian, Hongwei ;

Oro, Cristina ;

Abogadie, Fe ;

Delbridge, Lea M. D. ;

Thomas, Walter G. .

CELLULAR SIGNALLING, 2011, 23 (11) :1767-1776

← 1 2 3 4 5 →